ZYBERNO
Stock Report
Updated Jun 10, 2026

SMART FOR LIFE, INC. (SMFL)

Healthcare • Over The Counter

$0.00

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
7.0/100
POOR BUSINESS
SMART FOR LIFE, INC. (SMFL) scores 7/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-1,936.2%)
Debt-to-Equity (Solvency Risk):CRITICAL (6.89x)
Operating Margin (Operational Efficiency):CRITICAL (-332.8%)
Return on Capital (Capital Efficiency):CRITICAL (-101.4%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

SMART FOR LIFE, INC. (SMFL) stock report — Zyberno Score 7/100 (POOR BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, SMFL generated -$8.11M in Owner Earnings. Reinvestment rate: 26.3%.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.00
Market Cap:$3.46K

Valuation Multiples (3)

P/B Ratio:0.00x
P/S Ratio:0.00x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$7.47M
B. Profitability Assessment

Return Metrics (5)

ROA:-122.5%
Reinvestment Rate:26.3%
Fundamental Growth Rate (g):-26.7%

Margin Analysis (3)

Operating Margin Ttm:-332.8%
Net Margin Ttm:-532.3%
Ebitda Margin:-292.8%

TTM Performance (3)

Gross Margin Ttm:46.6%
Operating Margin Ttm:-332.8%
Net Margin Ttm:-532.3%

Yield Metrics (2)

Earnings Yield:-$2.21M
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):-50.0%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:0.17x
Quick Ratio:0.09x
Cash Ratio:0.00x

Leverage Analysis (3)

Debt To Equity Ttm:6.89x
Debt-to-Equity Ratio:6.89x
Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-8.38x
Times Interest Earned:-8.38

Capital Structure (4)

Working Capital:-8,188,884.00
Cash And Cash Equivalents:35,608.00
Long Term Debt:$5.32M
Net Debt:$7.47M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $3.41M
Linear Growth: -50.0%
📊 Click to view full SMFL Revenue analysis & methodology →
Cost Of Revenue Ttm:$1.82M

Profitability Breakdown (2)

Gross profit TTM: $1.59M
Linear Growth: -50.0%
📊 Click to view full SMFL Gross Profit analysis & methodology →
-$11.36M

Bottom Line Performance (3)

-$18.17M
Income Before Tax:$0.00
Ebitda Ttm:-9,994,457.00

Operating Expenses (5)

Operating Expenses:12,949,539.00
R And D Expense:0.00
Sga Expense:1,810,507.00
Income Tax Expense:$0.00
Interest Expense:2,046,324.00

Expense Ratios (3)

R And D To Revenue Percentage:0.0%
Sga To Revenue Percentage:142.6%
Ebitda Margin:-292.8%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$12.73M
Current Assets:$1.66M
Ppe Net:1,426,922.00
Goodwill:3,045,000.00
Intangible Assets:$6.71M

Liability Structure (4)

Total Liabilities:11,787,285.00
Current Liabilities:9,849,777.00
Long Term Debt:$5.32M
Short Term Debt:$2.18M

Equity & Capital (3)

Equity:$938.46K
Retained Earnings:-$76.01M
Common Stock:7,936,508.00

Working Capital Items (3)

Accounts Receivable:98,036.00
Inventory:747,172.00
Accounts Payable:3,624,886.00

Special Items (2)

Contract Liabilities:409,820.00
Stock Based Compensation:22,717.00
C. Cash Flow Analysis

Operating Activities (2)

-$6.01M-$8.11M

Investment Activities (1)

Investing Cash Flow:$0.00

Financing Activities (3)

Financing Cash Flow:$406.80K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$1.54M
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:1,364,611.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-162.08
-$22.06
Earnings Per Share Ttm:-$5.25

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.99
Operating Cash Flow Per Share:-$1.69

Book Value & Capital (2)

Book Value Per Share:$0.27
Cash Per Share:0.01

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.23x
Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:34.82x
Days Sales Outstanding Ttm:10.48

Inventory Management (2)

Inventory Turnover Ttm:2.44x
Days Inventory Outstanding Ttm:149.61

Payables & Cash Cycle (2)

Days Payable Outstanding:725.84
Cash Conversion Cycle:-565.75
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:0.00
Quality Score:15.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (1)

-$8.11M

Damodaran Growth Analysis (2)

Reinvestment Rate:26.3%
Fundamental Growth Rate (g):-26.7%
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):-50.0%

Other Growth Rates (2)

Gross Profit Growth Rate (Linear):-50.0%
Book Value Growth Rate (Linear):-50.0%
C. Company Profile & Context

Corporate Information (6)

Symbol:SMFL
Company Name:SMART FOR LIFE, INC.
Sector:Healthcare
Industry:Pharmaceuticals
Exchange:Over The Counter
Country:Unknown

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:3.46M
Shares Outstanding Basic:3.46M
Shares Outstanding Diluted:3.46M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-06-10 20:40:20 UTC
Data Timestamp:2026-06-10T20:40:20.804178
Scroll to Top